MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,053,476 | +1682.8% | 75,688 | +2720.0% | 0.04% | +1750.0% |
| Q2 2023 | $620,004 | -42.3% | 2,684 | -83.8% | 0.00% | 0.0% |
| Q3 2022 | $1,075,000 | +98.7% | 16,534 | +118.7% | 0.00% | +100.0% |
| Q2 2022 | $541,000 | +452.0% | 7,559 | +513.1% | 0.00% | – |
| Q3 2021 | $98,000 | -24.6% | 1,233 | -7.5% | 0.00% | – |
| Q2 2021 | $130,000 | +19.3% | 1,333 | +42.9% | 0.00% | – |
| Q1 2021 | $109,000 | -70.0% | 933 | -71.4% | 0.00% | -100.0% |
| Q4 2020 | $363,000 | -16.0% | 3,265 | -10.2% | 0.00% | 0.0% |
| Q3 2020 | $432,000 | +2600.0% | 3,637 | +2554.7% | 0.00% | – |
| Q2 2020 | $16,000 | -88.9% | 137 | -91.8% | 0.00% | -100.0% |
| Q3 2019 | $144,000 | +80.0% | 1,666 | +117.5% | 0.00% | 0.0% |
| Q2 2019 | $80,000 | +7900.0% | 766 | +10842.9% | 0.00% | – |
| Q1 2019 | $1,000 | -95.7% | 7 | -99.6% | 0.00% | – |
| Q3 2016 | $23,000 | – | 1,824 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |